Akebia Therapeutics
AKBA
#9606
Rank
NZ$0.19 B
Marketcap
NZ$0.70
Share price
-8.71%
Change (1 day)
-74.47%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): NZ-$0.28

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.29. In 2025 the company made an earnings per share (EPS) of NZ-$0.03656 an increase over its 2024 EPS that were of NZ-$0.60.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.28665.99%
2025NZ-$0.03656-93.94%
2024NZ-$0.60-16.83%
2023NZ-$0.73-23.7%
2022NZ-$0.95-69.41%
2021NZ-$3.11-38.63%
2020NZ-$5.0617.37%
2019NZ-$4.312.79%
2018NZ-$4.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.60-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$31.77-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$12.25 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA